LPL Financial’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.49M Sell
33,326
-14,975
-31% -$3.1M ﹤0.01% 2558
2026
Q1
$10.8M Buy
48,301
+2,356
+5% +$587K ﹤0.01% 1932
2025
Q4
$11.1M Sell
45,945
-14,039
-23% -$3.59M ﹤0.01% 1848
2025
Q3
$16.4M Buy
59,984
+9,022
+18% +$2.46M ﹤0.01% 1487
2025
Q2
$13.1M Sell
50,962
-18,150
-26% -$4.33M ﹤0.01% 1529
2025
Q1
$15.5M Buy
69,112
+15,770
+30% +$3.68M 0.01% 1322
2024
Q4
$12.2M Buy
53,342
+20,135
+61% +$4.85M 0.01% 1395
2024
Q3
$8.11M Buy
33,207
+2,137
+7% +$478K ﹤0.01% 1627
2024
Q2
$5.95M Buy
31,070
+6,388
+26% +$1.3M ﹤0.01% 1729
2024
Q1
$4.89M Buy
24,682
+4,262
+21% +$781K ﹤0.01% 1801
2023
Q4
$3.51M Buy
20,420
+1,443
+8% +$222K ﹤0.01% 1935
2023
Q3
$2.81M Buy
18,977
+6,556
+53% +$1.19M ﹤0.01% 2016
2023
Q2
$2.71M Buy
12,421
+1,603
+15% +$357K ﹤0.01% 1999
2023
Q1
$2.37M Sell
10,818
-62
-0.6% -$13.5K ﹤0.01% 2000
2022
Q4
$2.26M Buy
10,880
+765
+8% +$168K ﹤0.01% 1980
2022
Q3
$2.21M Sell
10,115
-326
-3% -$74.2K ﹤0.01% 1907
2022
Q2
$2.19M Sell
10,441
-682
-6% -$145K ﹤0.01% 1953
2022
Q1
$2.7M Sell
11,123
-2,498
-18% -$604K ﹤0.01% 1829
2021
Q4
$3.55M Sell
13,621
-5,033
-27% -$1.31M ﹤0.01% 1677
2021
Q3
$4.92M Buy
18,654
+1,997
+12% +$546K ﹤0.01% 1400
2021
Q2
$4.11M Sell
16,657
-697
-4% -$147K ﹤0.01% 1482
2021
Q1
$3.37M Buy
17,354
+3,837
+28% +$769K ﹤0.01% 1487
2020
Q4
$2.87M Buy
13,517
+429
+3% +$85.5K ﹤0.01% 1439
2020
Q3
$2.24M Sell
13,088
-49
-0.4% -$9.05K ﹤0.01% 1390
2020
Q2
$2.52M Sell
13,137
-1,155
-8% -$189K ﹤0.01% 1228
2020
Q1
$2.1M Buy
14,292
+741
+5% +$118K ﹤0.01% 1159
2019
Q4
$2.1M Buy
13,551
+1,045
+8% +$151K ﹤0.01% 1322
2019
Q3
$1.69M Buy
12,506
+3,113
+33% +$408K ﹤0.01% 1368
2019
Q2
$1.15M Sell
9,393
-321
-3% -$35.6K ﹤0.01% 1631
2019
Q1
$1.01M Sell
9,714
-2,952
-23% -$305K ﹤0.01% 1644
2018
Q4
$1.44M Buy
12,666
+480
+4% +$51.4K ﹤0.01% 1266
2018
Q3
$1.41M Buy
12,186
+2,373
+24% +$260K ﹤0.01% 1418
2018
Q2
$1.02M Buy
9,813
+926
+10% +$93.7K ﹤0.01% 1608
2018
Q1
$875K Sell
8,887
-1,666
-16% -$157K ﹤0.01% 1707
2017
Q4
$894K Sell
10,553
-297
-3% -$24.5K ﹤0.01% 1603
2017
Q3
$835K Buy
10,850
+289
+3% +$22.1K ﹤0.01% 1563
2017
Q2
$822K Sell
10,561
-9
-0.1% -$644 ﹤0.01% 1507
2017
Q1
$757K Buy
10,570
+1,673
+19% +$116K 0.01% 1460
2016
Q4
$552K Buy
8,897
+226
+3% +$13.8K ﹤0.01% 1669
2016
Q3
$558K Sell
8,671
-196
-2% -$13K 0.01% 1614
2016
Q2
$565K Sell
8,867
-372
-4% -$21.9K ﹤0.01% 1567
2016
Q1
$536K Buy
9,239
+3,595
+64% +$203K ﹤0.01% 2123
2015
Q4
$296K Buy
+5,644
New +$318K ﹤0.01% 2549
2015
Q3
Sell
-3,678
Closed -$204K 2878
2015
Q2
$204K Sell
3,678
-1,309
-26% -$82.6K ﹤0.01% 2612
2015
Q1
$356K Buy
4,987
+440
+10% +$28.6K ﹤0.01% 2112
2014
Q4
$255K Hold
4,547
﹤0.01% 2301
2014
Q3
$225K Sell
4,547
-2,869
-39% -$146K ﹤0.01% 2365
2014
Q2
$375K Sell
7,416
-1,870
-20% -$92.7K ﹤0.01% 2027
2014
Q1
$415K Sell
9,286
-565
-6% -$25.4K ﹤0.01% 1876
2013
Q4
$464K Buy
9,851
+349
+4% +$17.7K ﹤0.01% 1776
2013
Q3
$532K Sell
9,502
-4,260
-31% -$207K ﹤0.01% 1608
2013
Q2
$621K Buy
+13,762
New +$653K ﹤0.01% 1415

Other funds holding RMD

LPL Financial's RMD Position: Q2 2026 in Review

LPL Financial reduced its ResMed (RMD) stake by 31% in Q2 2026, selling an estimated $3.1M and leaving 33,326 shares worth $6.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

LPL Financial first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.4M in Q3 2025. 485 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • LPL Financial held 33,326 shares of ResMed worth $6.49M as of Q2 2026.
  • LPL Financial sold 14,975 ResMed shares in Q2 2026, an estimated $3.1M.
  • ResMed made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2558 holding.
  • LPL Financial first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • LPL Financial's ResMed position peaked at $16.4M in Q3 2025.
  • 485 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.